Effect of enzyme replacement therapy (ERT) added to Home Mechanical Ventilation (HMV) in Adult Pompe disease
Citations Over Time
Abstract
Adult Pompe disease/acid maltase deficiency is an autosomal recessive disorder resulting in accumulation of glycogen in skeletal muscles, leading to myopathy frequently involving respiratory muscles. This involvement can cause respiratory insufficiency that may present as acute hypercapnic respiratory failure. Enzyme replacement therapy (ERT) with alpha - glucosidase alfa, the only disease-specific treatment, has been available as treatment option since 2006. ERT has shown efficacy concerning muscle strength and pulmonary function in adult patients as well as positive association with survival. We present two cases where addition of ERT to Home Mechanical Ventilation (HMV) showed improvements in lung function and gas exchange that may not be entirely attributable to nocturnal HMV and therefore may further indicate the beneficial role of ERT in conjunction with HMV in Adult Pompe disease.
Related Papers
- → Enzyme Replacement Therapy for Pompe Disease(2011)45 cited
- New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.(2014)
- → New insights into therapeutic options for Pompe disease(2011)22 cited
- [A case of Pompe disease treated with acid alpha-glucosidase].(2009)
- → P.74Uptake of recombinant human GAA in a primary muscle cell differentiation system(2019)